US Broker Ratings

Tourmaline Bio, Inc. (TRML) Investor Outlook: Biotech’s Promising Pipeline Amidst Technical Strengths

Tourmaline Bio, Inc. (NASDAQ: TRML) is making waves in the biotechnology industry with its innovative approach to tackling immune and inflammatory diseases. Headquartered in New York, the company has quickly..

PureTech Health plc (PRTC) Stock Analysis: A Biotech Powerhouse with 542% Revenue Growth

PureTech Health plc (NASDAQ: PRTC), a U.S.-based biotechnology firm, has been attracting attention with its staggering 542.70% revenue growth. Despite its relatively modest market capitalization of $404.95 million, this innovative..

Savara, Inc. (SVRA) Stock Analysis: A Biotech Contender with a 68.95% Potential Upside

Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical firm, is making waves in the biotechnology sector with its promising focus on rare respiratory diseases. Headquartered in Langhorne, Pennsylvania, Savara has captured..

Autolus Therapeutics plc (AUTL): Investor Outlook with a 466.80% Potential Upside

Autolus Therapeutics plc (NASDAQ: AUTL) presents a compelling opportunity for investors looking to delve into the biotechnology sector, with a potential upside of 466.80% according to analyst projections. The London-based..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with Strategic Innovations in Medical Devices

Avanos Medical, Inc. (NYSE: AVNS) operates at the intersection of healthcare innovation and medical technology—a critical juncture for investors seeking to engage with the medical devices sector. Headquartered in Alpharetta,..

Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a 110% Potential Upside Amidst Market Challenges

Owens & Minor, Inc. (NYSE: OMI), a pivotal player in the healthcare sector, is currently navigating through a complex market landscape. The company’s stock, trading at $2.71, presents a noteworthy..

EyePoint, Inc. (EYPT) Stock Analysis: A Potential 97% Upside with an Eye on Biotech Innovations

EyePoint, Inc. (NASDAQ: EYPT) stands as a compelling opportunity in the biotechnology sector, promising significant potential upside for astute investors. With a market capitalization of $1.51 billion, EyePoint is a..

SIGA Technologies Inc. (SIGA): Investor Outlook with Strong Forward P/E as a Highlight

SIGA Technologies Inc. (NASDAQ: SIGA) stands out in the healthcare sector as a commercial-stage pharmaceutical company with a targeted focus on the health security market. Headquartered in New York, SIGA..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating the Volatility with a 19.72% Upside Potential

For investors keeping a close eye on the biotechnology sector, Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) presents an intriguing mix of innovation and volatility. As a key player in cell..

Orthofix Medical Inc. (OFIX) Investor Outlook: Analyzing the 50.40% Potential Upside

Orthofix Medical Inc. (NASDAQ: OFIX) stands at a fascinating crossroads for investors, blending its robust presence in the healthcare sector with a strategic focus on medical devices. With a market..

Precigen, Inc. (PGEN) Stock Analysis: A Biotech Play with Over 100% Upside Potential

Precigen, Inc. (NASDAQ: PGEN) is making waves in the biotechnology sector with its innovative gene and cell therapy platforms. Based in Germantown, Maryland, this clinical-stage biopharmaceutical company is poised for..

Replimune Group, Inc. (REPL) Investor Outlook: Navigating Biotech Potential with a 24.59% Upside

Replimune Group, Inc. (NASDAQ: REPL) is garnering attention in the biotechnology sector with its promising oncolytic immunotherapy product candidates aimed at treating cancer. This clinical-stage company, headquartered in Woburn, Massachusetts,..

Talkspace, Inc. (TALK) Investor Outlook: Analysts Predict a 33% Upside for This Healthcare Innovator

In the rapidly evolving healthcare sector, Talkspace, Inc. (NASDAQ: TALK) stands out as a forward-thinking player in the field of mental health services. With a market capitalization of $611.25 million,..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Volatility with a 20.48% Potential Upside

Cross Country Healthcare, Inc. (NASDAQ: CCRN) offers a comprehensive range of talent management services for healthcare clients across the United States. With a market capitalization of $262.73 million, this Boca..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 131% Potential Upside

LifeMD, Inc. (NASDAQ: LFMD), a dynamic player in the healthcare sector, is capturing the attention of investors with its robust telehealth services and significant growth potential. As a direct-to-patient telehealth..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: A 46% Upside Potential Amid Strong Buy Ratings

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) has been capturing the attention of investors with its significant potential upside and unanimous buy ratings from analysts. As a clinical-stage biotechnology company, Dianthus is..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: 76.57% Upside Potential and Robust Revenue Growth

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a promising player in the healthcare sector, has caught the attention of investors with its impressive revenue growth and substantial upside potential. This Deer Park,..

Personalis, Inc. (PSNL) Stock Analysis: Exploring a 30.8% Potential Upside in the Healthcare Sector

For investors with a keen eye on the healthcare sector, Personalis, Inc. (NASDAQ: PSNL) presents a compelling opportunity, underscored by a potential upside of 30.8% based on its average target..

Semler Scientific (SMLR) Stock Analysis: A Deep Dive into Its 278% Potential Upside

Semler Scientific, Inc. (SMLR), a U.S.-based provider of medical devices, is currently trading at $17.35, presenting a compelling opportunity for investors seeking high growth potential in the healthcare sector. At..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds